Fundraising Fox

Andy Weymann

Investor

Venture Partner, Frontiers in Health & Bio Investments at Verve Ventures · Chairman of Board at Becapio

Küssnacht am Rigi, Schwyz, Switzerland

Writes $1.1M – $2.2M checks

About

Andy Weymann, an MD/MBA with CMO and Global Head of Clinical Strategy experience including Smith & Nephew, bridges founders, regulators, clinicians and acquirers through C-suite, board and venture work.

Invests in

AI & Machine LearningClimate TechDeep TechHardwareHealthtechRobotics

Chairman of Board at Becapio

Intro paths

In turn, Andy can intro founders to Becapio's investors below.

Co-founders at Becapio

DLDan Livovsky
Dan LivovskyCo-Founder | Medical Director
JLJoseph Lysy
Joseph LysyCo-Founder | Medical Director

Experience

  1. BeCapioChairman of the Boardcurrent2024 — present
  2. SolasCureChairman of the Boardcurrent2023 — presentCambridge, England, United Kingdom
  3. GelmetixCEO and Director of the Boardcurrent2020 — presentManchester Area, United Kingdom
  4. JellagenChairman of the Board of Directorscurrent2023 — presentCardiff, Wales, United Kingdom
  5. VirtaMedDirector Board Of Directorscurrent2021 — presentZurich, Switzerland
  6. Hyalex Orthopaedics Inc.Senior Medical Advisorcurrent2020 — present
  7. 30 TECHNOLOGYSenior Medical Advisorcurrent2020 — present
  8. Smith& NephewChief Medical Officer and Senior Vice President Scientific, Clinical and Medical Affairs2012 — 2020Baar
  9. Smith& NephewDirector Board Of Directors2019 — 2020
  10. Smith& NephewDirector Board Of Directors2017 — 2020Baar, Zug, Switzerland
  11. Smith& NephewVice President Medical Education Global2006 — 2012
  12. AO FoundationManaging Director AO Education1997 — 2006
  13. Spital DavosResident (orthopedics, trauma, sports medicine)1995 — 1997Davos
  14. Schulthess Clinic ZurichResident (orthopedics)1994 — 1995Zurich, Switzerland

Skills & more

Non-Executive Director1Board Level3BiotechnologyMedical Devices99Orthopedic99Surgery91Medical Education63Healthcare53Product Launch50Hospitals44Clinical Research42Orthopedics43
+12 moreFDASports MedicineMarket DevelopmentBusiness StrategyClinical TrialsMarketing StrategyCommercializationCompetitive AnalysisLeadershipStrategic PlanningStrategyManagement

Languages English · French · German · Spanish

  • Advanced Coperate Director SeminarHarvard Business School Executive Education

From Andy's professional profile.

Colleagues at Verve Ventures

Frequently asked questions

Who is Andy Weymann?
Andy Weymann, an MD/MBA with CMO and Global Head of Clinical Strategy experience including Smith & Nephew, bridges founders, regulators, clinicians and acquirers through C-suite, board and venture work.
Where does Andy Weymann work?
Andy Weymann is Venture Partner, Frontiers in Health & Bio Investments at Verve Ventures and Chairman of Board at Becapio.
What does Andy Weymann invest in?
Andy Weymann invests in AI & Machine Learning, Climate Tech, Deep Tech, Hardware, Healthtech, Robotics.
What check size does Andy Weymann write?
Andy Weymann typically writes checks of $1.1M – $2.2M.
Where did Andy Weymann go to school?
Andy Weymann studied at Harvard Business School (Audit Committees in a New Era of Governance, Corporate Board Program); Harvard Business School (Compensation Committees: New Challenges, New Solutions); Harvard Business School (Making Corporate Boards More Effective, Cooperate Boards).

Same school

Shared employers